Expect Abbott To Continue To See Steady Earnings Growth In The Near Term

Abbott Labs (NYSE:ABT) recently posted its Q4 results, which were in line with our estimates. Medical Devices continued to see steady sales growth, led by electrophysiology, and strong FreeStyle Libre sales. Established Pharmaceutical Products revenue were down in mid-single digits, primarily due...